Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers | Zendy

Alexandra Gangi | Zendy; Ilana Cass | Zendy; Daniel Y. Paik | Zendy; Galinos Barmparas | Zendy; Beth Y. Karlan | Zendy; Catherine Dang | Zendy; Andrew Li | Zendy; Christine Walsh | Zendy; B.J. Rimel | Zendy; Farin Amersi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers

Author(s) -

Alexandra Gangi,

Ilana Cass,

Daniel Y. Paik,

Galinos Barmparas,

Beth Y. Karlan,

Catherine Dang,

Andrew Li,

Christine Walsh,

B.J. Rimel,

Farin Amersi

Publication year - 2014

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2014.1081

Subject(s) - medicine , brca mutation , breast cancer , ovarian cancer , prophylactic mastectomy , cancer , oncology , mammography , incidence (geometry) , gynecology , mastectomy , physics , optics

BRCA mutation carriers are at increased risk of developing breast cancer. However, the incidence of breast cancer after a diagnosis of epithelial ovarian cancer (EOC), one of the tubal/peritoneal cancers collectively referred to as pelvic serous carcinomas, is not well known. Optimal breast cancer surveillance and detection for these patients have also not been well characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research